Cigna Corporation (CI) is listed on NYSE and operates in the Medical - Healthcare Plans industry (Healthcare sector).
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
| Rating | Analysts |
|---|---|
| Strong Buy | 1 |
| Buy | 30 |
| Hold | 8 |
| Sell | 0 |
| Strong Sell | 0 |
Cigna Corporation, headquartered in Bloomfield, Connecticut, operates in the healthcare sector, specifically within the medical healthcare plans industry. The company offers a variety of insurance and related services in the United States. Its Evernorth segment provides health services such as pharmacy, benefits management, care delivery, and intelligence solutions to health plans, employers, government entities, and healthcare providers. The Cigna Healthcare segment delivers medical, pharmacy, behavioral health, dental, vision, and health advocacy services for both insured and self-insured clients. It also offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, along with individual health insurance plans available on and off public exchanges. Internationally, Cigna provides healthcare coverage and benefits for mobile individuals and employees of multinational companies. Additionally, the company offers permanent insurance contracts to corporations for employee benefit obligations. Cigna distributes its products through brokers, consultants, and directly to employers, unions, groups, and individuals, as well as via private and public exchanges. Founded in 1792, Cigna has a long-standing presence in the healthcare industry.
Over the past three fiscal years, the company has demonstrated robust revenue growth, with a consistent increase at an 18.7% CAGR, rising from $195.3 billion in 2023 to $274.9 billion in 2025. Despite this top-line expansion, profitability metrics have shown some compression. Gross margin decreased by 3.4pp from 12.9% to 9.5%, and operating margin contracted by 1.1pp from 4.4% to 3.3%. Net margin was inconsistent, ultimately decreasing by 0.5pp to 2.2%. This margin compression occurred even as EPS showed an inconsistent trend, ending higher at $22.17 in 2025 from $17.39 in 2023. Cash generation has been under pressure, with both operating and free cash flows consistently decreasing, resulting in a decline in FCF from $10.2 billion to $8.4 billion, and FCF margin narrowing by 2.2pp to 3.1%. The company's capital efficiency improved, as evidenced by a consistent increase in asset turnover to 1.75, and a decrease in capex intensity to 0.44%. The company also enhanced shareholder value through a 10.4% reduction in share count, amplifying per-share gains. However, liquidity remains a concern, with a current ratio below 1, indicating potential challenges in meeting short-term obligations. Overall, while revenue growth is strong, the company faces challenges in maintaining margins and cash flow amidst its expansion.
Recent developments for The Cigna Group (NYSE: CI) are centered around its upcoming financial performance and institutional trading activities. The company is set to release its first quarter 2026 financial results on April 30, 2026, with expectations of potentially beating estimates, as suggested by Zacks Investment Research. This anticipation follows the company's extensive global reach, maintaining sales capabilities in over 30 markets and serving more than 185 million customer relationships worldwide. In the realm of institutional trading, significant activity was noted with Banque Pictet & Cie SA increasing its holdings in Cigna, while Davidson Investment Advisors and Assetmark Inc. trimmed their positions. Notably, Arrowstreet Capital Limited Partnership and Dodge & Cox have also adjusted their stakes, reflecting ongoing portfolio management among major investors. Additionally, Cigna Healthcare was recognized for its leading digital experience by JD Power, marking its second consecutive year of top ranking in customer satisfaction. Meanwhile, The Cigna Group Foundation has expanded its Impact Fund to Memphis, inviting local nonprofits to apply for grants aimed at improving healthcare access. These developments highlight Cigna's strategic focus on financial performance, investor relations, and community engagement.